Today: 29 April 2026
Enact Holdings stock jumps 10% as ACT rallies on fresh buyback plan and earnings
4 February 2026
1 min read

Enact Holdings stock jumps 10% as ACT rallies on fresh buyback plan and earnings

New York, February 4, 2026, 15:20 EST — Regular session

Enact Holdings’ stock jumped roughly 10.5% to $44.58 in midafternoon trading, reaching an intraday peak of $44.76 and outperforming its mortgage insurance peers. Radian Group advanced around 2.9%, MGIC Investment climbed about 3.0%, Essent Group added roughly 2.6%, and NMI Holdings rose close to 4.8%. Meanwhile, the S&P 500 ETF slipped about 0.2%.

The run-up matters because Enact is ramping up capital returns just as investors sort steady premium earners from those vulnerable to a housing slump. A larger buyback boosts earnings per share by cutting the share count, but it also shows the board thinks capital levels can handle increased payouts.

Late Tuesday, Enact’s board approved a fresh $500 million share repurchase plan while holding its quarterly dividend steady at $0.21 per share. The dividend will be paid on March 19 to those registered as shareholders by February 26. This new buyback authorization adds to an existing $350 million program, which still has roughly $30 million available, the company noted. “The Board’s authorization … reflects the strength of our balance sheet,” CEO Rohit Gupta said. SEC

Enact’s Q4 results gave investors plenty to chew on ahead of its buyback. The mortgage insurer reported GAAP net income of $177 million, or $1.22 per diluted share, alongside adjusted operating income of $179 million, or $1.23 per diluted share. Losses hit $18 million, with the loss ratio dropping to 7%. The company released $60 million in reserves after more delinquent loans “cured” than expected and trimmed its claim-rate forecast on new delinquencies from 9% down to 8%. On the capital front, Enact’s PMIERs sufficiency—a key metric for staying in Fannie Mae and Freddie Mac’s good graces—stood at 162%, roughly $1.9 billion above the required threshold. SEC

On Wednesday’s earnings call, management told analysts it plans to return about $500 million in capital in 2026 and forecasted operating expenses between $215 million and $220 million, excluding reorganization costs. CFO Dean Mitchell expressed strong confidence in hitting that $500 million target but noted risks from business performance, loss trends, the macro environment, and regulatory shifts. Analysts drilled Enact on possible policy changes, including an FHA “re-rate” cut and other affordability initiatives. Investing.com

The repurchase plan includes provisions aimed at stabilizing Enact’s ownership structure. According to a share repurchase agreement dated February 2, Genworth Holdings holds 114,588,830 Enact shares—roughly 81% of the total outstanding—and will sell shares back to Enact in line with Enact’s open-market buybacks. This will follow a 4.3 ratio designed to preserve Genworth’s stake.

The bigger picture is straightforward: mortgage insurers appear cash-rich when home prices hold steady and borrowers stay current. But that can shift fast if unemployment climbs or the housing market falters, driving up delinquencies and claims, and forcing companies to curb buybacks to preserve capital.

Traders are closely monitoring how fast Enact moves on the new authorization. Meanwhile, all eyes turn to Genworth, which reports earnings after the close on February 23, followed by a conference call on February 24.

Stock Market Today

  • PG&E's Preferred Shares Yield Exceeds 6.5% Amid Discounted Trading
    April 29, 2026, 3:44 PM EDT. Shares of PG&E Corp's 5% Redeemable 1st Preferred (PCG.PRD) yielded over 6.5% on Wednesday, driven by quarterly dividends annualized at $1.25 and stock prices dropping to $19.15. The preferred shares trade at a 25.24% discount to liquidation preference, significantly wider than the 19.03% average discount in the utilities sector. PCG.PRD outpaced the sector average yield of 6.62%, reflecting investor caution. Meanwhile, PG&E's common shares (PCG) also rose 0.5% during the same session. The premium yield signals market unease over PG&E's financial risk but offers income-seeking investors a higher return in preferred utilities stocks.

Latest article

Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

Vita Coco Stock Surges After COCO Earnings Beat and Coconut Water Demand Lifts 2026 Outlook

29 April 2026
Vita Coco shares jumped 27% Wednesday after first-quarter net sales rose 37% to $180 million, beating analyst expectations. The company raised its 2026 revenue outlook to $720–$735 million and lifted adjusted EBITDA guidance. Diluted earnings reached $0.50 per share, up from $0.31 a year earlier. Gross margin improved to 39.9% despite higher logistics and tariff costs.
Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

Marathon Petroleum Stock Jumps Before Earnings as Refining Margins Put Wall Street on Alert

29 April 2026
Marathon Petroleum shares rose 3.2% to $240.05 Wednesday as investors anticipated its May 5 earnings report, following a surge in fuel margins during the first quarter. Phillips 66 and Valero also gained after posting stronger-than-expected results. Marathon’s Robinson refinery in Illinois began planned maintenance in March. U.S. gasoline prices hit $4.18 a gallon, the highest since 2022, according to AAA.
Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

Why MaxLinear Stock Is Surging as AI Data-Center Demand Rewrites the Story

29 April 2026
MaxLinear shares rose about 34% to $69.58 on Wednesday after Loop Capital upgraded the stock and raised its target to $75. The surge followed a first-quarter report showing infrastructure revenue up 136% to become the company’s largest segment. Total revenue climbed 43% to $137.2 million. MaxLinear guided second-quarter revenue to $160–$170 million, citing strong demand for data-center optical products.
Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks
Previous Story

Fortive stock jumps on upbeat 2026 profit view after Q4 beat, buybacks

Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell
Next Story

Boston Scientific (BSX) stock dives on electrophysiology sales miss — what to watch after the bell

Go toTop